These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 30951948

  • 1. S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension.
    Yang J, Si D, Zhao Y, He C, Yang P.
    Biomed Pharmacother; 2019 Jun; 114():108799. PubMed ID: 30951948
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
    Peng WX, Ye C, Dong WT, Yang LL, Wang CQ, Wei ZA, Wu JH, Li Q, Deng J, Zhang J.
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1234-1243. PubMed ID: 28454497
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway.
    Zhao JJ, Wu ZF, Wang L, Feng DH, Cheng L.
    PLoS One; 2016 Jun; 11(7):e0159805. PubMed ID: 27459539
    [Abstract] [Full Text] [Related]

  • 5. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y, Jiang T, Wang R, He S, Guo M, Zuo J, He D.
    BMC Complement Altern Med; 2015 Mar 24; 15():77. PubMed ID: 25887296
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M, Matsuo K, Tada T, Fukushima H, Furuta H, Ozeki S, Kadowaki T, Yamamoto K, Okamoto M, Jimi E.
    Carcinogenesis; 2011 Nov 24; 32(11):1634-40. PubMed ID: 21890459
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B, Wu D, Cheng Y, Huang P, Liu Y, Gan L, Liu C, Cao Y.
    Scand J Immunol; 2020 May 24; 91(5):e12874. PubMed ID: 32090353
    [Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
    McGonigle JS, Giachelli CM, Scatena M.
    Angiogenesis; 2009 May 24; 12(1):35-46. PubMed ID: 19105036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
    Sano T, Akeda K, Yamada J, Takegami N, Sudo T, Sudo A.
    BMC Musculoskelet Disord; 2019 May 17; 20(1):225. PubMed ID: 31101043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.